Skip to Main Content

Author Details

Markus Ball
Institute of Pathology, Heidelberg University Hospital
2010
30
13
PMIDPaper TitleJournal TitlePublished Year
36367572Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue.Virchows Arch2023
37586177Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications.Lung Cancer2023
37059713Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis.Cell Death Discov2023
37141769Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas.Lung Cancer2023
37327584Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD).Transl Oncol2023
35058282Histological and molecular plasticity of ALK-positive non-small-cell lung cancer under targeted therapy: a case report.Cold Spring Harb Mol Case Stud2022
35871236Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing.Br J Cancer2022
36053528Progenitor Hierarchy of Chronic Myelomonocytic Leukemia Identifies Inflammatory Monocytic-Biased Trajectory Linked to Worse Outcomes.Blood Cancer Discov2022
32761393Tumor budding assessed according to the criteria of the International Tumor Budding Consensus Conference determines prognosis in resected esophageal adenocarcinoma.Virchows Arch2021
34253584Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia.Clin Cancer Res2021
32647293Analysis of tumor mutational burden: correlation of five large gene panels with whole exome sequencing.Sci Rep2020
31932945[Molecular diagnostics of cytological specimens].Pathologe2020
33106634Cancer therapy shapes the fitness landscape of clonal hematopoiesis.Nat Genet2020
30995123Leveraging Single-Cell RNA Sequencing Experiments to Model Intratumor Heterogeneity.JCO Clin Cancer Inform2019
31762957Comparison of <i>in situ</i> and extraction-based methods for the detection of <i>MET</i> amplifications in solid tumors.Comput Struct Biotechnol J2019
30026572Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML.Leukemia2019
28694526Intrapatient functional clonality deconvoluted by coupling intracellular flow cytometry and next-generation sequencing in human leukemia.Leukemia2018
35135101Somatic Sequencing Identifies Trametinib-Responsive Myelodysplastic Syndrome and Finds Acquired Clonal Hematopoiesis of Indeterminate Potential.JCO Precis Oncol2018
29866652Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing Assays.Clin Cancer Res2018
29661788Germ line tissues for optimal detection of somatic variants in myelodysplastic syndromes.Blood2018
27927582Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study.Lancet Oncol2017
28159734Monocyte subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosis.Blood2017
28576879Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML.Blood2017
27707735When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemia.Blood2016
23565222Molecular identification of falciparum malaria and human tuberculosis co-infections in mummies from the Fayum depression (Lower Egypt).PLoS One2013
23553074First insights into the metagenome of Egyptian mummies using next-generation sequencing.J Appl Genet2013
22426219New insights into the Tyrolean Iceman's origin and phenotype as inferred by whole-genome sequencing.Nat Commun2012
29539370Eleonora of Toledo (1522-1562): Evidence for tuberculosis and leishmaniasis co-infection in Renaissance Italy.Int J Paleopathol2012
22257739Visceral Leishmaniasis during Italian Renaissance, 1522-1562.Emerg Infect Dis2012
20159872Ancestry and pathology in King Tutankhamun's family.JAMA2010
  • 1 - 30 of 30

Recommended Authors

Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 3
Jin-Li Luo
University of Leicester
Career Start Year 2015
Number of shared co-authors 0
Mara Rosenberg
Broad Institute of MIT and Harvard
Career Start Year 2013
Number of shared co-authors 3
Hiroko Tanaka
Tokyo Medical and Dental University
Career Start Year 2012
Number of shared co-authors 1
Francesco Favero
Universita del Piemonte Orientale
Career Start Year 2010
Number of shared co-authors 0
Bartlomiej Przychodzen
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 1
Sabah Kadri
Abbvie Inc., Genomics Research Center
Career Start Year 2009
Number of shared co-authors 0
Christopher A Miller
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 4
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 0
Moritz Gerstung
German Cancer Research Centre DKFZ
Career Start Year 2007
Number of shared co-authors 2
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 2
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 3
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 3
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 0
Chip Stewart
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 5
Catrina Fronick
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Career Start Year 2004
Number of shared co-authors 3
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 4
Peter J Campbell
Wellcome Sanger Institute
Career Start Year 2003
Number of shared co-authors 7
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 2
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 4
Thomas Ernst
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 1
Fei Yang
Oregon Health & Science University
Career Start Year 2002
Number of shared co-authors 2
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 6
Jason D Merker
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 1998
Number of shared co-authors 2
Anthony J Iafrate
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 5
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 1
Seishi Ogawa
Kyoto University
Career Start Year 1993
Number of shared co-authors 6
Christopher D Gocke
Johns Hopkins University School of Medicine
Career Start Year 1992
Number of shared co-authors 0
Mark J Routbort
University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 0
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 4

Collaborators

Daniel Kazdal
Institut fur Pathologie, Universitatsklinikum Heidelberg
Co-authored papers 6
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 6
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 6
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 5
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Co-authored papers 4
Susanne Beck
Vrije Universiteit Brussel (VUB)
Co-authored papers 3
Olaf Neumann
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 3
Martina Kirchner
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 3
Anna-Lena Volckmar
Institut fur Pathologie, Universitatsklinikum Heidelberg
Co-authored papers 2
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 2
Rafael Bejar
Moores Cancer Center, university of california san diego
Co-authored papers 2
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Co-authored papers 2
Kelly L Bolton
Washington University School of Medicine
Co-authored papers 2
Dana E Rollison
Moffitt Cancer Center
Co-authored papers 2
Michael F Berger
Co-authored papers 2
Huriye Seker-Cin
Institute of Pathology, Heidelberg University Hospital
Co-authored papers 2
Mignon L Loh
University of Washington
Co-authored papers 1
Timothy C Burn
Incyte Research Institute
Co-authored papers 1
Daniel W Kelly
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Matthew J Walter
Washington University School of Medicine in St. Louis
Co-authored papers 1
Michael W Deininger
University of Utah Huntsman Cancer Institute
Co-authored papers 1
Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Co-authored papers 1
James K Hicks
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 1
Larry Norton
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Howard L McLeod
Center for Precision Medicine and Functional Genomics, Utah Tech University
Co-authored papers 1
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 1
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Co-authored papers 1
Ulrich Lehmann
Institute of Pathology, Hannover Medical School
Co-authored papers 1
Jonathan S Berg
University of North Carolina
Co-authored papers 1
Thomas Longerich
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 1
Release 1.2